Following the Centers for Disease Control and Prevention's (CDC's) recommendation, U.S. Department of Health and Human Services Secretary Xavier Becerra has announced that Novavax's Covid-19 vaccine for adults will be made available to people aged 18 and above who require or prefer a protein-based vaccine.
CDC's recommendation comes barely a week after the Food and Drug Administration's authorization of the Novavax Covid-19 vaccine for emergency use in individuals 18 years and older as a primary vaccination series against COVID-19, and an Advisory Community on Immunization Practices' recommendation for use of this vaccine.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.